Press
Kardium selected as Medical/Digital Technology Company of the Year
08/05/2021
Life Sciences BC has selected Kardium Inc. as the Medical/Digital Technology Company of the Year.
More precise and effective: Innovative catheter technology in the cardiac catheterization laboratory
07/20/2021
Cardiologists at the RHÖN-KLINIKUM Campus Bad Neustadt apply state-of-the-art single catheter complete solution for the treatment of atrial fibrillation for the first time.
01/25/2021
Kardium's Globe Mapping and Ablation System is intended to disrupt a roughly $6-billion market for treating atrial fibrillation, which is expected to grow by 15 per cent a year as Baby Boomers age.
B.C. companies seeking new markets take advantage of favourable travel policies (BIV)
09/30/2020
The EU’s favourable polic, is creating advantages for Canadian firms like Kardium looking to expand globally amid the pandemic.
Kardium completes first commercial procedures with the Globe Mapping and Ablation System
09/11/2020
Early successes in roll-out of world’s most complete solution for atrial fibrillation
06/30/2020
Medical device company gets certification for European sales.
Kardium® announces successful results from the GLOBAL-AF study (Financial Post)
10/08/2019
Global-AF study demonstrated a 76% percent freedom from atrial fibrillation at 12 months after a single treatment with the Globe System.
02/07/2019
Financing was led by funds and accounts advised by T. Rowe Price Associates, Inc., and included participation from other new and existing Kardium shareholders.
02/07/2019
Kardium has raised an undisclosed amount in a new financing round.
Kardium seeking CE Mark for breakthrough treatment of atrial fibrillation (BioTuesdays)
06/26/2018
Kardium hopes to receive marketing approval in Europe and launch its breakthrough Globe Mapping and Ablation System.